Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma
European Journal of Cancer2016Vol. 57, pp. 91–103
Citations Over TimeTop 1% of 2016 papers
Related Papers
- → Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer(2021)37 cited
- → Assessing the significance of KRAS G12C mutation: Clinicopathologic features, treatments, and survival outcomes in a real-world KRAS mutant non-small cell lung cancer cohort.(2020)3 cited
- → Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer(2020)2 cited
- → KRAS gene amplification to define a distinct molecular subgroup of gastroesophageal adenocarcinoma.(2016)
- → 127P RAS, RAF and NF1 oncogenic mutations in KRAS-mutated lung adenocarcinoma(2022)